pemafibrate
Kowa Pharmaceuticals
['cardio']
the #prominent trial failed to show that pemafibrate improved cardiovascular outcomes among patients with diabetes and hypertriglyceridemia. #aha22 
cardiologist & life long learner & AFL04 & AUTF10 & Kosuyolu Heart Education and Research Hospital &Phd student bioengineering